Variety of drugs top ibuprofen for migraine
Triptan, ergot and anti-emetic medications appear to be two to five times more effective than ibuprofen for treating migraine, researchers reported on Nov. 29, 2023 in Neurology. “There… read more.
Triptan, ergot and anti-emetic medications appear to be two to five times more effective than ibuprofen for treating migraine, researchers reported on Nov. 29, 2023 in Neurology. “There… read more.
Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical… read more.
Patients treated with the investigative PCSK9 inhibitor recaticimab have achieved highly significant reducions in bad cholesterol, and they have done so with less frequent injections than patients treated… read more.
Researchers from a study of patients treated for acute COVID-19 report that virologic rebound takes place in about 20.8 percent of subjects treated with nirmatrelvir-ritonavir (N-R, Paxlovid) versus… read more.
Women who get a false-positive mammogram reading are more likely to develop breast cancer over the ensuing 20 years, researchers reported on Nov. 2, 2023 in JAMA Oncology. As… read more.
Only 20-25 minutes of moderate-to vigorous-physical activity every day may offset the heightened risk of death from a sedentary lifestyle, researchers reported Oct. 24, 2023 in the British Journal… read more.
In patients with prostate cancer with high-risk biochemical recurrence, enzalutamide plus standard-treatment leuprolide is superior to leuprolide monotherapy for metastasis-free survival. And enzalutamide monotherapy is also superior to… read more.
Researchers report that patients treated for treatment-resistant depression with esketamine NS (nasal spray), a form of ketamine, achieve better and more durable outcomes than similar patients treated with… read more.
Tirzepatide. a once weekly GIP and GLP-1 receptor agonist, treats early-onset type 2 diabetes as effectively as it treats type 2 diabetes diagnosed later in life, researchers reported… read more.
Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up… read more.
Among persons with PAD (peripheral artery disease) home-based walking exercise appears to improve 6-minute walk (6MW) more than supervised treadmill exercise. Investigators reported this finding on Sept 21,… read more.
Persons with an evening ‘chronotype”’ (going to bed late and waking up late), have a 19 percent increased risk of diabetes compared to those with a morning chronotype,… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.